Details of the Drug Combination
General Information of Drug Combination (ID: DC0CJLF)
| Drug Combination Name |
Acetohydroxamic Acid Trimethobenzamide
|
|||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Indication |
|
|||||||||||||||||
| Component Drugs | Acetohydroxamic Acid | Trimethobenzamide | ||||||||||||||||
| Small molecular drug | Small molecular drug | |||||||||||||||||
|
|
|||||||||||||||||
| 2D MOL | 2D MOL | |||||||||||||||||
| 3D MOL | 3D MOL | |||||||||||||||||
| High-throughput Screening Result | Testing Cell Line: KBM-7 | |||||||||||||||||
| Zero Interaction Potency (ZIP) Score: 19.73 | ||||||||||||||||||
| Bliss Independence Score: 19.73 | ||||||||||||||||||
| Loewe Additivity Score: 42.74 | ||||||||||||||||||
| LHighest Single Agent (HSA) Score: 42.75 | ||||||||||||||||||
Molecular Interaction Atlas of This Drug Combination
| Molecular Interaction Atlas (MIA) | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Indication(s) of Acetohydroxamic Acid |
|
|||||||||||||||||||||||||||
|
Acetohydroxamic Acid Interacts with 1 DTT Molecule(s)
|
||||||||||||||||||||||||||||
| Indication(s) of Trimethobenzamide |
|
|||||||||||||||||||||||||||
References
